Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2006-08-13 16:44:29 UTC |
---|
Update Date | 2022-03-07 02:49:20 UTC |
---|
HMDB ID | HMDB0004321 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | (-)-Limonene |
---|
Description | Limonene is a monoterpene with a clear colourless liquid at room temperature, a naturally occurring chemical which is the major component in oil of oranges. Limonene is widely used as a flavour and fragrance and is listed to be generally recognized as safe in food by the Food and Drug Administration (21 CFR 182.60 in the Code of Federal Regulations, U.S.A.). Limonene is a botanical (plant-derived) solvent of low toxicity. Mild skin irritation may occur from exposure to limonene and oxidation products of limonene may produce dermal sensitization, and may have irritative and bronchoconstrictive airway effects; however, data are scant and more studies are required. Limonene has been shown to cause a male rat-specific kidney toxicity referred to as hyaline droplet nephropathy. Furthermore, chronic exposure to limonene causes a significant incidence of renal tubular tumours exclusively in male rats. Limonene is one of the active components of dietary phytochemicals that appears to be protective against cancer (PMID:16563357 , 15499193 , 15325315 , 2024047 ). |
---|
Structure | InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(-)-(S)-Limonene | ChEBI | (-)-(4S)-Limonene | ChEBI | (4S)-1-Methyl-4-isopropenylcyclohex-1-ene | ChEBI | (4S)-4-Isopropenyl-1-methylcyclohexene | ChEBI | (S)-(-)-p-Mentha-1,8-diene | ChEBI | (S)-1-Methyl-4-(1-methylethenyl)cyclohexene | ChEBI | (S)-p-Mentha-1,8-diene | ChEBI | 4AlphaH-p-mentha-1,8-diene | ChEBI | L-Limonen | ChEBI | L-Limonene | ChEBI | 4-Isopropenyl-1-methyl-1-cyclohexene | HMDB | Limonene | HMDB | (+)-Limonene | HMDB | AISA 5203-L (+)limonene | HMDB | Dipentene | HMDB | 1-Methyl-4-(1-methylethenyl)cyclohexene | HMDB | Limonene, (+-)-isomer | HMDB | (D)-Limonene | HMDB | 4-Mentha-1,8-diene | HMDB | Limonene, (S)-isomer | HMDB | Limonene, (R)-isomer | HMDB | (R)-(+)-Limonene | HMDB | (R)-4-Isopropenyl-1-methylcyclohexene | HMDB | (+)-(R)-4-Isopropenyl-1-methylcyclohexene | HMDB | (4R)-1-Methyl-4-(1-methylethenyl)cyclohexene | HMDB | D-Limonene | HMDB | 4 Mentha 1,8 diene | HMDB | D Limonene | HMDB | (-)-alpha-Limonene | HMDB | (-)-Α-limonene | HMDB | (4S)-1-Methyl-4-(1-methylethenyl)cyclohexene | HMDB | (4S)-Limonene | HMDB | (S)-(-)-Limonene | HMDB | (S)-1-Methyl-4-(prop-1-en-2-yl)cyclohex-1-ene | HMDB | (S)-4-Isopropenyl-1-methyl-1-cyclohexene | HMDB | (S)-Limonene | HMDB | beta-Limonene | HMDB | L-Carvene | HMDB | Β-limonene | HMDB | (-)-Limonene | ChEBI |
|
---|
Chemical Formula | C10H16 |
---|
Average Molecular Weight | 136.234 |
---|
Monoisotopic Molecular Weight | 136.125200512 |
---|
IUPAC Name | (4S)-1-methyl-4-(prop-1-en-2-yl)cyclohex-1-ene |
---|
Traditional Name | (-)-limonene |
---|
CAS Registry Number | 5989-54-8 |
---|
SMILES | CC(=C)[C@H]1CCC(C)=CC1 |
---|
InChI Identifier | InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m1/s1 |
---|
InChI Key | XMGQYMWWDOXHJM-SNVBAGLBSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as menthane monoterpenoids. These are monoterpenoids with a structure based on the o-, m-, or p-menthane backbone. P-menthane consists of the cyclohexane ring with a methyl group and a (2-methyl)-propyl group at the 1 and 4 ring position, respectively. The o- and m- menthanes are much rarer, and presumably arise by alkyl migration of p-menthanes. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Prenol lipids |
---|
Sub Class | Monoterpenoids |
---|
Direct Parent | Menthane monoterpenoids |
---|
Alternative Parents | |
---|
Substituents | - P-menthane monoterpenoid
- Monocyclic monoterpenoid
- Branched unsaturated hydrocarbon
- Cycloalkene
- Cyclic olefin
- Unsaturated aliphatic hydrocarbon
- Unsaturated hydrocarbon
- Olefin
- Hydrocarbon
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Liquid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | -74.3 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.014 mg/mL at 25 °C | Not Available | LogP | 4.57 | LI,J & PURDUE,EM (1995) |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.15 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 17.4234 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.1 minutes | 32390414 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2237.0 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 651.2 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 242.5 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 412.8 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 248.6 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 623.6 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 763.2 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 162.3 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1412.8 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 494.3 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1312.8 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 490.8 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 433.2 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 544.9 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 644.2 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 22.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized |
---|
General References | - Flamm WG, Lehman-McKeeman LD: The human relevance of the renal tumor-inducing potential of d-limonene in male rats: implications for risk assessment. Regul Toxicol Pharmacol. 1991 Feb;13(1):70-86. [PubMed:2024047 ]
- Aggarwal BB, Shishodia S: Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol. 2006 May 14;71(10):1397-421. Epub 2006 Feb 23. [PubMed:16563357 ]
- Tsuda H, Ohshima Y, Nomoto H, Fujita K, Matsuda E, Iigo M, Takasuka N, Moore MA: Cancer prevention by natural compounds. Drug Metab Pharmacokinet. 2004 Aug;19(4):245-63. [PubMed:15499193 ]
- DeWitt C, Bebarta V: Botanical solvents. Clin Occup Environ Med. 2004 Aug;4(3):445-54, v-vi. [PubMed:15325315 ]
|
---|